摘要
眼睑皮脂腺癌为发生于睑板腺、Zeis腺和睫毛囊周围腺体的恶性肿瘤，在我国是仅次于基底细胞癌的第二大常见眼睑恶性肿瘤，其临床表现多样，复发率高，易发生转移。国际上对该病按照标准临床分期给予规范的术中冰冻控制性肿瘤切除手术治疗，术后进行标准化随访，大大降低了该病的复发及转移风险。而目前我国临床对于该病的诊断和治疗工作比较混乱，缺乏标准的临床分期、规范的手术治疗和术后随访，这势必造成我国眼睑皮脂腺癌的复发率高及预测性差。因此，本文从眼睑皮脂腺癌的诊断及临床分期、术中冰冻控制性肿瘤切除手术、眼睑缺损修复及重建方式、术后随访工作4个方面，强调积极规范我国眼睑皮脂腺癌的临床诊断和治疗工作具有重要的临床意义。
Eyelid sebaceous carcinoma is a malignant tumor originating from Meibomian glands, Zeis glands, and other glands surrounding hair follicles. It is the second most common eyelid malignancy, following basal cell carcinoma, in China. Considering its diversified clinical manifestations and strong tendency for recurrence and metastasis, standardized cancer staging, surgical excision with frozen section control, and postsurgical follow-up has been internationally adopted with the aim to considerably reduce the risk of recurrence and metastasis. However, the lack of standardized and normalized staging, surgical treatment and follow-up in China inevitably caused high recurrence rate and low predictability of prognosis of eyelid sebaceous carcinoma. Therefore, it is of great significance to standardize the clinical diagnosis and treatment of eyelid sebaceous carcinoma in China. （Chin J Ophthalmol, 2018, 54： 481-483）
作者
李冬梅
Li Dongmei(Beijing Tongren Eye Center,Beijing Tongren Hospital,Capital Medical University,Belting Ophthalmology ＆ Visual Sciences Key Lab.,Beijing 100730,China)
出处
《中华眼科杂志》
CAS
CSCD
北大核心
2018年第7期481-483,共3页
Chinese Journal of Ophthalmology
基金
国家卫生和计划生育委员会公益性行业专项项目（201402014）
关键词
眼睑肿瘤
腺癌
皮脂性
肿瘤分期
眼外科手术
随访研究
Eyelid neoplasms
Adenocarcinoma
sebaceous
Neoplasm staging
Ophthalmologic surgical procedures
Follow-up studies
